RICI HEALTH (01526) plans to repurchase company shares not exceeding 1 billion Hong Kong dollars.

RICI HEALTH (01526) announced that the Board of Directors has been granted a general authorization by the Company's shareholders at the Company's Annual General Meeting held on June 19, 2025, to repurchase up to 10% of the total issued shares of the Company (excluding treasury shares) on the date of the Annual General Meeting. The Board of Directors has approved a resolution for the Company to repurchase shares within the authorized limit using its own funds (excluding any proceeds raised by the Company on the main board of the Hong Kong Stock Exchange) for an amount not exceeding HKD 100 million. The repurchase period will be from the date of approval by the Board of Directors until the end of the Company's next Annual General Meeting in 2026. The Company plans to treat the repurchased shares as treasury shares, which may be cancelled, sold, or transferred as needed in the future (including for the purpose of equity incentive plans). The Board of Directors believes that the share repurchase not only reflects a high recognition of the Company's intrinsic value but also demonstrates sufficient confidence in the long-term prospects of the business. This move will ultimately enhance the Company's value proposition, creating long-term and stable returns for shareholders, which is in line with the overall interests of the Company and its shareholders.